万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生1>>肿瘤学

MOLECULAR CANCER THERAPEUTICS《分子癌症治疗学》 (官网投稿)

简介
  • 期刊简称MOL CANCER THER
  • 参考译名《分子癌症治疗学》
  • 核心类别 SCIE(2023版), 高质量科技期刊(T3), 目次收录(知网),外文期刊,
  • IF影响因子
  • 自引率1.50%
  • 主要研究方向医学-ONCOLOGY肿瘤学

主要研究方向:

等待设置主要研究方向
医学-ONCOLOGY肿瘤学

MOLECULAR CANCER THERAPEUTICS《分子癌症治疗学》(月刊). Molecular Cancer Therapeutics will focus on basic research that has implications for cancer ther...[显示全部]
征稿信息

万维提示:

1、投稿方式:官网投稿。

2、期刊网址:

http://mct.aacrjournals.org/

3、投稿网址:

https://mct.msubmit.net/cgi-bin/main.plex

4、期刊刊期:月刊,一年出版12期。

          20220111日星期二

                     

 

投稿须知【官网信息】

                      

MOLECULAR CANCER THERAPEUTICS

This page provides an overview of basic submission instructions. Authors should be familiar with the AACR journals broader Information for Authors before submitting their manuscript.

See About Molecular Cancer Therapeutics for an overview of the journaland Categories of Publication for descriptions of the different article types. Our Author Services Center has resources to assist authors in the preparation of their manuscript.

Submission Requirements

All Submissions

To be entered in the SmartSubmit data fields

First name, middle initial(s) and last name (all authors)

Institution (all authors)

Country (all authors)

City (Corresponding Author only)

Zip/Postal Code (Corresponding Author only)

Work telephone number (Corresponding Author only)

Valid unique e-mail address (all authors)

Title (limit of 165 characters including spaces)

Running title (limit of 60 characters including spaces)

Abstract

Contact information (e-mail address and institution) of each suggested reviewer (optional).

To be provided in the uploaded files

Cover letter (not seen by reviewers)

Copies of any related manuscripts currently submitted or in press elsewhere.

A detailed conflict of interest statement on the title page of the manuscript. If there are no conflicts, please write the following on the cover page: "The authors declare no potential conflicts of interest." More information can be found at Conflicts of Interest.

Initial Submission

Initial submissions need not adhere closely to the journal's format and length requirements.

To facilitate peer review, authors are strongly encouraged to provide a single Word or PDF file containing the main text and all display items. Each figure should be presented in sequential order and adjacent to its legend, ideally where it is first called out in the text.

Figures may be supplied separately at initial submission in PDF, JPG, TIFF, PNG, EPS, PS or PowerPoint format. Authors should be familiar with AACR policies on image data.

Supplementary Data should be supplied separately. Individual files must not exceed 50 MB each in size and are generally limited to 8 or fewer in number.

Authors of First Disclosures are encouraged to submit an optional Graphical Abstract - a single image containing a clear and condensed diagrammatic summary of the major findings and biological implications. Graphical Abstracts should not include data items of any type or figures from the manuscript and should be distinct from any model figures in the manuscript. This should be an illustrative image with little or no text and should not contain heavily saturated colors. If the manuscript is accepted and the graphical abstract is deemed suitable for publication, this image will be included in the article along with the Abstract and in the online Table of Contents. If you wish to submit a Graphical Abstract for consideration, please upload it along with your submission and select "Graphical Abstract" as the file type. In the caption box on the submission form, please include a short caption for your Graphical Abstract that describes your image in 25 words or less. Please note, all Graphical Abstracts, including the image and any accompanying text, may be enhanced and redrawn at the discretion of the editorial office.

Revised Submissions

Publication Charges

Detailed fee and discount information can be found at Publication Fees If the corresponding, first, or last author is an active AACR member, the corresponding author will receive both a 5% discount on the total charges, excluding any open access fees. The AACR Membership section of the submission form must be filled out to receive this discount. Country-specific discounts are available for authors from many countries.

Getting Help

For additional information about specific submission questions please click on the Help Icons  throughout the system.

Manuscript Status

The submission process is complete as soon as you approve your manuscript for consideration. You may obtain the status of your manuscript at any time by:

Logging into the system with your password.

Clicking on the link represented by your manuscript tracking number and abbreviated title.

Clicking on the "Check Status" link at the bottom of the displayed page.

This procedure will display detailed tracking information about where your manuscript is in the submission/peer review process.

For more detailed status information, contact the journals Editorial Office.

Please press HOME to continue.

……

更多详情:

https://mct.msubmit.net/cgi-bin/main.plex?form_type=display_auth_instructions


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭